JP2022528566A5 - - Google Patents
Info
- Publication number
- JP2022528566A5 JP2022528566A5 JP2021560499A JP2021560499A JP2022528566A5 JP 2022528566 A5 JP2022528566 A5 JP 2022528566A5 JP 2021560499 A JP2021560499 A JP 2021560499A JP 2021560499 A JP2021560499 A JP 2021560499A JP 2022528566 A5 JP2022528566 A5 JP 2022528566A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- age
- amd
- diabetic retinopathy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962828616P | 2019-04-03 | 2019-04-03 | |
| US62/828,616 | 2019-04-03 | ||
| US201962899279P | 2019-09-12 | 2019-09-12 | |
| US62/899,279 | 2019-09-12 | ||
| PCT/CN2020/082765 WO2020200241A1 (en) | 2019-04-03 | 2020-04-01 | Method for treating ocular diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022528566A JP2022528566A (ja) | 2022-06-14 |
| JP2022528566A5 true JP2022528566A5 (https=) | 2022-09-06 |
| JP7461663B2 JP7461663B2 (ja) | 2024-04-04 |
Family
ID=72662774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021560499A Active JP7461663B2 (ja) | 2019-04-03 | 2020-04-01 | 眼疾患の処置方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11033603B2 (https=) |
| EP (1) | EP3946414B1 (https=) |
| JP (1) | JP7461663B2 (https=) |
| KR (1) | KR20210149087A (https=) |
| CN (1) | CN113795268B (https=) |
| SG (1) | SG11202110659SA (https=) |
| TW (1) | TWI818168B (https=) |
| WO (1) | WO2020200241A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI788083B (zh) * | 2021-11-03 | 2022-12-21 | 葡萄王生技股份有限公司 | 蟬花菌絲體活性物質用於治療黃斑部病變之用途 |
| US20240316144A1 (en) * | 2023-03-20 | 2024-09-26 | ZIH YUAN TANG Biotechnology Co, Ltd. | Pharmaceutical composition and method for inhibiting angiogenesis |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0327316A (ja) * | 1989-06-23 | 1991-02-05 | Kitasato Inst:The | 高脂血症治療剤 |
| KR20080031474A (ko) * | 2005-07-27 | 2008-04-08 | 유니버시티 오브 플로리다 리서치 파운데이션, 아이엔씨. | 안구 질환의 치료를 위한 열충격의 사용 |
| CN101669939A (zh) * | 2009-09-22 | 2010-03-17 | 中山大学 | 恩镰孢菌素类化合物在制备抗耐药结核菌药物中的应用 |
| US20140275091A1 (en) * | 2013-03-15 | 2014-09-18 | Coyote Pharmaceuticals, Inc. | Ocular formulations comprising geranylgeranylacetone derivatives for intraocular delivery |
| US20140371158A1 (en) * | 2013-06-14 | 2014-12-18 | Georgia Regents University | Beauvericin compositions and methods thereof for inhibiting the hsp90 chaperone pathway |
| CN109200066A (zh) * | 2017-07-07 | 2019-01-15 | 葡萄王生技股份有限公司 | 蝉花活性物质及其用于预防、延缓或治疗白内障的用途 |
-
2020
- 2020-04-01 JP JP2021560499A patent/JP7461663B2/ja active Active
- 2020-04-01 CN CN202080025566.3A patent/CN113795268B/zh active Active
- 2020-04-01 US US16/837,259 patent/US11033603B2/en active Active
- 2020-04-01 KR KR1020217034481A patent/KR20210149087A/ko active Pending
- 2020-04-01 EP EP20782491.3A patent/EP3946414B1/en active Active
- 2020-04-01 SG SG11202110659SA patent/SG11202110659SA/en unknown
- 2020-04-01 TW TW109111356A patent/TWI818168B/zh active
- 2020-04-01 WO PCT/CN2020/082765 patent/WO2020200241A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022183183A5 (https=) | ||
| JP2022191257A5 (https=) | ||
| NZ710575A (en) | Pharmaceutical compositions for the treatment of diabetes mellitus | |
| JP2015096532A5 (https=) | ||
| BRPI0819081A8 (pt) | Formulação oftálmica aquosa, processo para preparar a mesma, e, método para inibir, tratar ou prevenir doenças oculares e doença ou condição relacionada, em um paciente em necessidade de tal tratamento | |
| TN2010000251A1 (fr) | N-acetyl-dl-leucine medicament neuro et retino protecteur | |
| JP2014502641A5 (https=) | ||
| JP2013500977A5 (https=) | ||
| JP2019524897A5 (https=) | ||
| JP2017525769A5 (https=) | ||
| JP2022528566A5 (https=) | ||
| JP2023541766A5 (https=) | ||
| JP2019532926A5 (https=) | ||
| JP2019532026A5 (https=) | ||
| JP2024512425A5 (https=) | ||
| JOP20230133A1 (ar) | استخدام منشطات sGC لمعالجة الأمراض العينية | |
| RU2017112930A (ru) | Офтальмологические составы для доставки лекарств и защиты переднего отдела глаза | |
| JP2021534160A5 (https=) | ||
| JP2018524306A5 (https=) | ||
| FI3886917T3 (fi) | Kuparinanoklusterit, niitä sisältävät koostumukset ja neurodegeneratiivisten sairauksien hoito | |
| JP2018511639A5 (https=) | ||
| JP2008540528A5 (https=) | ||
| JP2019524888A5 (https=) | ||
| JP2007527417A5 (https=) | ||
| JP2019502719A5 (https=) |